|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.790 USD | -2.16% |
|
+0.74% | +2.11% |
| 06-22 | Evolus, Inc.(NasdaqGM:EOLS) added to S&P Pharmaceuticals Select Industry Index | CI |
| 05-11 | Evolus, Inc. Launches Estyme Injectable Hyaluronic Acid Gels Collection in Europe | CI |
| Market Cap | 447M 392M 362M 335M 634M 42.82B 647M 4.35B 1.69B 20.95B 1.68B 1.64B 72.73B | P/E 2026 * |
-13.7x | P/E 2027 * | -46.3x |
|---|---|---|---|---|---|
| Enterprise Value | 574M 504M 465M 430M 814M 54.98B 831M 5.59B 2.17B 26.9B 2.16B 2.11B 93.39B | EV / Sales 2026 * |
1.74x | EV / Sales 2027 * | 1.49x |
| Free-Float |
83.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Evolus, Inc.
| 1 day | -2.16% | ||
| 1 week | +0.74% | ||
| Current month | -2.16% | ||
| 1 month | +1.65% | ||
| 3 months | +66.01% | ||
| 6 months | +18.29% | ||
| Current year | +2.11% |
| 1 week | 6.77 |  | 7.24 |
| 1 month | 6.42 | | 7.32 |
| Current year | 3.86 | | 7.32 |
| 1 year | 3.86 | | 10.2 |
| 3 years | 3.86 | | 17.82 |
| 5 years | 3.86 | | 17.82 |
| 10 years | 2.85 | | 39.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Moatazedi
CEO | Chief Executive Officer | 48 | 05/05/2018 |
Tatjana Mitchell
DFI | Director of Finance/CFO | 48 | 07/09/2025 |
Jon Yerbury
COO | Chief Operating Officer | - | 31/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
David Gill
BRD | Director/Board Member | 71 | 11/02/2018 |
Albert White
BRD | Director/Board Member | 56 | 30/06/2024 |
Vikram Malik
CHM | Chairman | 63 | 31/12/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-19 | Sell | Chief Technology Officer | 3,119 | 0.0048% | ||
| 03-19 | Sell | Chief Executive Officer | 13,669 | 0.0211% | ||
| 03-15 | Fiscal year | Chief Executive Officer | 251,698 | 0.3891% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | +0.74% | -26.67% | -5.03% | 447M | |
| -1.60% | +2.02% | +56.34% | +168.94% | 1,084B | |
| -1.44% | +3.71% | +69.07% | +65.40% | 634B | |
| -0.75% | +0.67% | +33.18% | +86.52% | 447B | |
| -0.42% | -2.02% | +28.69% | +26.15% | 330B | |
| -8.94% | -10.06% | +26.19% | +28.45% | 295B | |
| -0.82% | -2.20% | +28.34% | +45.95% | 285B | |
| -0.79% | -3.27% | -27.51% | -39.51% | 218B | |
| -0.03% | +1.84% | +23.90% | +68.30% | 199B | |
| -0.40% | +7.82% | +22.29% | +82.50% | 169B | |
| Average | -1.73% | +2.34% | +23.38% | +52.77% | 366.03B | |
| Weighted average by Cap. | -1.70% | +2.48% | +40.29% | +85.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 330M 290M 268M 247M 469M 31.64B 478M 3.22B 1.25B 15.48B 1.24B 1.21B 53.75B | 388M 340M 314M 290M 550M 37.12B 561M 3.77B 1.47B 18.17B 1.46B 1.42B 63.06B |
| Net income | -33.31M -29.21M -26.97M -24.92M -47.24M -3.19B -48.19M -324M -126M -1.56B -125M -122M -5.42B | -10.56M -9.26M -8.55M -7.9M -14.98M -1.01B -15.28M -103M -39.95M -495M -39.66M -38.79M -1.72B |
| Net Debt | 127M 111M 103M 95.03M 180M 12.16B 184M 1.24B 480M 5.95B 477M 466M 20.66B | 132M 116M 107M 98.77M 187M 12.64B 191M 1.28B 499M 6.19B 496M 485M 21.47B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | US$6.790 | -2.16% | 1,279,941 |
| 07/07/26 | US$6.940 | -0.72% | 705,989 |
| 06/07/26 | US$6.990 | +1.30% | 643,642 |
| 02/07/26 | US$6.900 | +2.37% | 534,868 |
| 01/07/26 | US$6.740 | -2.88% | 567,581 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EOLS Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
